ACE2 and chronic obstructive pulmonary disease: It has been hypothesized that this greater severity is related to the higher expression of angiotensin-converting enzyme II (ACE-2) in the lower airways of active smokers with COPD, as this is the receptor that SARS-CoV-2 binds to and uses to enter epithelial cells (35).